Does Blue Cross Blue Shield decide whether weight-loss medication is covered?

Blue Cross Blue Shield is not one insurer, so there is no single answer. The Blue Cross and Blue Shield Association describes itself as "a national federation of independent, community-based and locally operated Blue Cross and Blue Shield companies", and each of those companies sets its own coverage. Some have stopped covering Wegovy and Zepbound for weight loss altogether: Blue Cross and Blue Shield of Vermont made them a benefit exclusion from January 1, 2026. Others leave the decision to each employer: Blue Cross and Blue Shield of Texas tells employer groups that for weight management "plan coverage is optional".

Does Blue Cross and Blue Shield of Vermont cover GLP-1s for weight loss?

All members: From January 1, 2026, GLP-1 drugs FDA-approved for weight loss, including Wegovy, Zepbound and Saxenda, are a benefit exclusion, and members who keep using them pay the full cost. Coverage continues with prior approval for type 2 diabetes, and for Wegovy prescribed to reduce cardiovascular risk in adults with diagnosed cardiovascular disease and obesity.

Does Blue Cross Blue Shield of North Dakota cover GLP-1s for weight loss?

Fully insured large group plans: Coverage for weight-loss drugs, including GLP-1s and oral medications, is removed from January 1, 2026, at each plan’s anniversary. Small group and individual plans: Coverage continues under North Dakota’s Essential Health Benefit requirements. Wegovy tablets joined the formularies on February 1, 2026, with prior authorization. Self-funded employer plans: The employer decides. Blue Cross Blue Shield of North Dakota says self-funded clients will need to choose to include weight-loss drugs with their plan.

Does Blue Cross and Blue Shield of Texas cover GLP-1s for weight loss?

Self-funded employer groups: Coverage for weight management is optional for each group. Groups that elect it keep the Zepbound auto-injector on the drug lists under utilization management. The Zepbound KwikPen, sold only direct to consumers, is excluded from coverage.

Does Blue Shield of California cover GLP-1s for weight loss?

Some commercial PPO and HMO plans: From January 1, 2025, or the plan’s renewal, Wegovy and Zepbound are covered only where Blue Shield authorizes them as medically necessary for Class III obesity, and only alongside a weight loss program of reduced-calorie diet, physical activity and behavior therapy, before and during treatment. Members on those plans who do not qualify pay the full cost.

Does Blue Cross Blue Shield of Arizona cover GLP-1s for weight loss?

Group plans and individual plans: GLP-1s approved for type 2 diabetes, such as Ozempic, are covered only for type 2 diabetes and not for weight-loss management. The bulletin dates from August 2024.

Insurance plan

Does Blue Cross Blue Shield cover GLP-1s for weight loss?

Blue Cross Blue Shield is not one insurer, so there is no single answer. The Blue Cross and Blue Shield Association describes itself as "a national federation of independent, community-based and locally operated Blue Cross and Blue Shield companies", and each of those companies sets its own coverage.

Who decides, in their own words

Some have stopped covering Wegovy and Zepbound for weight loss altogether: Blue Cross and Blue Shield of Vermont made them a benefit exclusion from January 1, 2026. Others leave the decision to each employer: Blue Cross and Blue Shield of Texas tells employer groups that for weight management "plan coverage is optional".

By John Weeks Checked against the primary source September 11, 2026

Your own Blue plan decides first. Blue Cross Blue Shield is a federation of separate companies, and each one sets its own coverage. Inside many of them the employer then decides again, so the plan named on your card and the company you work for can both matter.

What each Blue Cross Blue Shield plan we read decided

7 decisions from 5 member companies, each read from that company's own published document. A company we have not read is not listed, and nothing is inferred for it.

What each Blue Cross Blue Shield plan we read decided about weight-loss GLP-1s.
Plan and members	Position	What it decided
Blue Cross and Blue Shield of Vermont All members	Not covered	From January 1, 2026, GLP-1 drugs FDA-approved for weight loss, including Wegovy, Zepbound and Saxenda, are a benefit exclusion, and members who keep using them pay the full cost. Coverage continues with prior approval for type 2 diabetes, and for Wegovy prescribed to reduce cardiovascular risk in adults with diagnosed cardiovascular disease and obesity. Effective January 1, 2026 · document undated · read September 11, 2026
Blue Cross Blue Shield of North Dakota Fully insured large group plans	Not covered	Coverage for weight-loss drugs, including GLP-1s and oral medications, is removed from January 1, 2026, at each plan’s anniversary. Effective January 1, 2026 · document dated August 7, 2025 · read September 11, 2026
Blue Cross Blue Shield of North Dakota Small group and individual plans	Prior authorization	Coverage continues under North Dakota’s Essential Health Benefit requirements. Wegovy tablets joined the formularies on February 1, 2026, with prior authorization. Effective February 1, 2026 · document dated January 29, 2026 · read September 11, 2026
Blue Cross Blue Shield of North Dakota Self-funded employer plans	Employer decides	The employer decides. Blue Cross Blue Shield of North Dakota says self-funded clients will need to choose to include weight-loss drugs with their plan. Effective January 1, 2026 · document dated August 7, 2025 · read September 11, 2026
Blue Cross and Blue Shield of Texas Self-funded employer groups	Employer decides	Coverage for weight management is optional for each group. Groups that elect it keep the Zepbound auto-injector on the drug lists under utilization management. The Zepbound KwikPen, sold only direct to consumers, is excluded from coverage. document dated May 20, 2026 · read September 11, 2026
Blue Shield of California Some commercial PPO and HMO plans	Prior authorization	From January 1, 2025, or the plan’s renewal, Wegovy and Zepbound are covered only where Blue Shield authorizes them as medically necessary for Class III obesity, and only alongside a weight loss program of reduced-calorie diet, physical activity and behavior therapy, before and during treatment. Members on those plans who do not qualify pay the full cost. Effective January 1, 2025 · document dated November 2024 · read September 11, 2026
Blue Cross Blue Shield of Arizona Group plans and individual plans	Other indications only	GLP-1s approved for type 2 diabetes, such as Ozempic, are covered only for type 2 diabetes and not for weight-loss management. The bulletin dates from August 2024. Effective May 1, 2024 · document dated August 2024 · read September 11, 2026

Blue Cross and Blue Shield of Vermont

All members Not covered

From January 1, 2026, GLP-1 drugs FDA-approved for weight loss, including Wegovy, Zepbound and Saxenda, are a benefit exclusion, and members who keep using them pay the full cost. Coverage continues with prior approval for type 2 diabetes, and for Wegovy prescribed to reduce cardiovascular risk in adults with diagnosed cardiovascular disease and obesity.

Effective January 1, 2026 · document undated · read September 11, 2026
Blue Cross Blue Shield of North Dakota

Fully insured large group plans Not covered

Coverage for weight-loss drugs, including GLP-1s and oral medications, is removed from January 1, 2026, at each plan’s anniversary.

Effective January 1, 2026 · document dated August 7, 2025 · read September 11, 2026
Blue Cross Blue Shield of North Dakota

Small group and individual plans Prior authorization

Coverage continues under North Dakota’s Essential Health Benefit requirements. Wegovy tablets joined the formularies on February 1, 2026, with prior authorization.

Effective February 1, 2026 · document dated January 29, 2026 · read September 11, 2026
Blue Cross Blue Shield of North Dakota

Self-funded employer plans Employer decides

The employer decides. Blue Cross Blue Shield of North Dakota says self-funded clients will need to choose to include weight-loss drugs with their plan.

Effective January 1, 2026 · document dated August 7, 2025 · read September 11, 2026
Blue Cross and Blue Shield of Texas

Self-funded employer groups Employer decides

Coverage for weight management is optional for each group. Groups that elect it keep the Zepbound auto-injector on the drug lists under utilization management. The Zepbound KwikPen, sold only direct to consumers, is excluded from coverage.

document dated May 20, 2026 · read September 11, 2026
Blue Shield of California

Some commercial PPO and HMO plans Prior authorization

From January 1, 2025, or the plan’s renewal, Wegovy and Zepbound are covered only where Blue Shield authorizes them as medically necessary for Class III obesity, and only alongside a weight loss program of reduced-calorie diet, physical activity and behavior therapy, before and during treatment. Members on those plans who do not qualify pay the full cost.

Effective January 1, 2025 · document dated November 2024 · read September 11, 2026
Blue Cross Blue Shield of Arizona

Group plans and individual plans Other indications only

GLP-1s approved for type 2 diabetes, such as Ozempic, are covered only for type 2 diabetes and not for weight-loss management. The bulletin dates from August 2024.

Effective May 1, 2024 · document dated August 2024 · read September 11, 2026

If weight loss is excluded

A Blue plan that excludes weight-loss medication has not always excluded the drug. Blue Cross and Blue Shield of Vermont keeps GLP-1s covered with prior approval for type 2 diabetes, and for adults with diagnosed cardiovascular disease and obesity whose provider prescribes Wegovy to reduce the risk of certain cardiovascular events.

Worth knowing

Blue Cross and Blue Shield of Texas answers its own members’ question "Does insurance cover GLP-1s for weight loss?" with "Most plans don’t cover GLP-1s for weight loss", and says that where a plan does, "you likely will need approval from your health plan before you start treatment". Federal employees are covered by a separate Blue plan, the Federal Employee Program, which this site reads on its own page.

Read separately

Blue Cross Blue Shield Federal Employee Program Its own policy, read and dated on its own page.

Asking about one medicine instead

If the answer is no. Around 45% of initial prior authorizations for these drugs are refused, and 35 to 45% of first-level appeals are overturned. A refusal is not the end of the process, and the cash-pay routes are priced on this site alongside it.

Sources

Every claim above is checked against the primary text, and the date is the day we last opened it.

8 cited records

1
GLP-1 Drugs Could Raise Employer Health Premiums
Blue Cross Blue Shield Association Primary text read and checked Checked September 11, 2026
2
Frequently Asked Questions: 2026 Coverage Changes for GLP-1 Drugs FDA-Approved for Weight Loss
Blue Cross and Blue Shield of Vermont Primary text read and checked Checked September 11, 2026
3
BCBSND Shares Coverage Changes to Weight-Loss Drugs for 2026
Blue Cross Blue Shield of North Dakota Primary text read and checked Checked September 11, 2026
4
Pharmacy Update for Oral Wegovy Tablets
Blue Cross Blue Shield of North Dakota Primary text read and checked Checked September 11, 2026
5
GLP-1s for Weight Loss, Ask BCBSTX
Blue Cross and Blue Shield of Texas Primary text read and checked Checked September 11, 2026
6
What’s New in GLP-1 Coverage, Spring 2026
Blue Cross and Blue Shield of Texas Primary text read and checked Checked September 11, 2026
7
Weight Loss Medication Coverage Change Fact Sheet
Blue Shield of California Primary text read and checked Checked September 11, 2026
8
Coverage update for GLP-1 drugs, BlueConnect provider bulletin, August 2024
Blue Cross Blue Shield of Arizona Primary text read and checked Checked September 11, 2026